Cadila Pharma's Sepsivac gets nod from Philippines FDA for covid treatment
18 September 2021 | News
Cadila marketing and formulations teams coordinated with authorities to arrange multiple webinars
Image Credit: Shutterstock
Cadila Pharmaceuticals' Sepsivac recently received its first overseas approval in the Philippines. Philippines FDA, looking into efficacy and safety of the product in covid treatment, allowed special importation of the Sepsivac on compassionate grounds, which shall strengthen the fight against covid.
Cadila marketing and formulations teams coordinated with authorities to arrange multiple webinars. KOLs from India shared their clinical experience of Sepsivac with Philippines HCPs. The Cadila Pharmaceuticals team worked under the guidance of Dr Bakulesh Khamar, Executive Director – Research & Development, Dr Manjul Joshipura, Senior Vice President, Innovations and New Products, and Mahidhwaj Sisodia, EVP- International Formulations Business, which paved way for the first overseas approval of Sepsivac.
